A trial to assess the effect of sitagliptin on T lymphocytes and monocytes in patients with type 2 diabetes mellitus

Trial Profile

A trial to assess the effect of sitagliptin on T lymphocytes and monocytes in patients with type 2 diabetes mellitus

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Nov 2014

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Nov 2014 New trial record
    • 18 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top